glp 1 age restrictions Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection | Current Obesity Reports Updated guidance from the PCDS
Description
Microdosing promotes gradual, sustainable weight loss
Your provider should assess medical history, contraindications, and treatment readiness before any GLP-1 initiation
While highly effective for weight loss, approximately 1520% of users experience heartburn or acid reflux during treatment
Tirzepatide costs more than semaglutide, and GI side effects can be more pronounced during titration, though our B12-enhanced formulation helps reduce the severity of nausea
